The efficacy of aspirin in patients undergoing infra-inguinal bypass and indentification of high risk patients

International Angiology

Volumn 22, Issue 3, 2003, Pages 302-307

  Mahmood, A ^a   Sintler, M ^a   Edwards, A T ^a   Smith, S R G ^a   Simms, M H ^a   Vohra, R K ^a  

^a SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

Aspirin; Limb; Surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; BYPASS SURGERY; CLAUDICATION; CONTROLLED STUDY; DRUG EFFICACY; ENDOPROSTHESIS; FEMALE; GRAFT FAILURE; GRAFT PATENCY; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASE; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT INDICATION; VEIN GRAFT;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; BLOOD VESSEL PROSTHESIS IMPLANTATION; GRAFT OCCLUSION, VASCULAR; HUMANS; ISCHEMIA; LOWER EXTREMITY; MEDICAL AUDIT; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0344034667     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Dormandy J, Heeck L, Vig S. Lower-extremity arteriosclerosis as a reflection of a systemic process: implications for concomitant coronary and carotid disease. Semin Vasc Surg 1999;12:118-22.
2. Robless P, Mikhailidis DP, Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 2001;88:787-800.
3. Ray SA, Rowley MR, Bevan DH, Taylor RS, Dormandy JA. Hypercoagulable abnormalities and postoperative failure of arterial reconstruction. Eur J Vasc Endovasc Surg 1997;13:363-70.
4. Zeiger F, Stephan S, Hoheisel G, Pfeiffer D, Ruehlmann C, Koksch M. P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul Fibrinol 2000;11:723-8.
5. Sampram ES, Lindblad B, Dahlback B. Activated protein C resistance in patients with peripheral vascular disease. J Vasc Surg 1998;28:624-9.
6. Fujitani RM. Revision of the failing vein graft: outcome of secondary operations. Semin Vasc Surg 1993;6:118-29.
7. Tangelder MJ, Lawson JA, Algra A, Eikelboom BC. Systematic review of randomised controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischaemic events after infrainguinal bypass surgery. J Vasc Surg 1999;30:701-9.
8. The Dutch Bypass Oral anticoagulants or aspirin Study Group. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 2000;355:1104.
9. Sarac TP, Huber TS, Back MR, Ozaki CK, Carlton LM, Flynn TC et al. Warfarin improves the outcome of infainguinal vein bypass grafting at high risk for failure. J Vasc Surg 1998;28:446-57.
10. Becquemin JP. Effect of ticopidine on the long-term patency of saphenous-vein bypass grafts in the legs. N Engl J Med 1997;337:1726-31.
11. Green RM, Roedershelmer LR, DeWeese JA. Effects of aspirin and dipyidamole on expanded polytetrafluroethylene graft patency. Surgery 1982;92:1016-26.
12. Goldman MD, McCollum CN. A prospective randomised study to examine the effect of aspirin plus dipyridamole on the patency of prosthetic femoro-popliteal grafts. Vasc Surg 1984;18:217-21.
13. Kohler TR, Kaufman JL, Kacocyanis GP, Clowes A, Donaldson MC, Kelly E et al. Effect of aspirin on the patency of lower extremity bypass grafts. Surgery 1984;96: 462-6.
14. Donaldson DR, Salter MC, Kester RC, Rajah SM, Hall TJ, Sreeharan N et al. The influence of platelet inhibition on the patency of femoro-popliteal Dacron bypass grafts. Vasc Surg 1985;10:224-30.
15. McCollum C, Alexander C, Kerchington G, Franks PJ, Greenhalgh RM. Anti-platelet drugs in femoropopliteal vein bypasses: a multi-center trial. J Vasc Surg 1991;13:150-62.
16. Troeng T, Bergqvist D, Janson L. Incidence and causes of adverse outcomes of operation for chronic ischaemia of the leg. Eur J Surg 1994;160:17-25.
17. Dawson I, van Bockel JH, Brand R. Late nonfatal and fatal cardiac events after infrainguinal bypass for femoropopliteal occlusive disease during a 31-year period. J Vasc Surg 1993;18:249-60.
18. Lindblad B, Wakefield TW, Stanley TJ, Bergqvist D, Nichol BJ, Greenfield LJ et al. Pharmacological prophylaxis against postoperative graft occlusion after peripheral vascular surgery: a world-wide survey. Eur J Vasc Endovasc Surg 1995;9:267-71.
19. Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Br Med J 1994;308:159-68.
20. Golledge J. Vein grafts: haemodynamic forces on the endothelium - a review. Eur J Vasc Endovasc Surg 1997;14: 333-43.
21. Watson HR, Buth J, Schroeder TV, Simms MH, Horrocks M. Incidence of stenoses in femorodistal bypass vein grafts in a mulicentre study. Eur J Vasc Endovasc Surg 2000;20:67-71.
22. Zurbrugg HR, Musci M, Sanger S, Gutersohn A, Mulling C, Wellnhofer E et al. Prevention of venous graft sclerosis with clopidogrel and aspirin combined with a mesh tubing in a dog model of arteriovenous bypass grafting. Eur J Vasc Endovasc Surg 2001;22:337-41.
23. Dobrin PB, Golan J, Fareed J, Blakeman B, Littoy FN. Pre-vs postoperative pharmacologic inhibition of platelets: effect on intimal hyperplasia in canine autogenous vein grafts. J Cardiovasc Surg (Torino) 1992;33:705-9.
24. Smout J, Stansby G. Aspirin resistance. Br J Surg 2002;89: 4-5.
25. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK et al. Clopidogrel in unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33.
26. Berger PB. Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement? Curr Control Trials Cardiovasc Med 2000;1:83-7.
27. CAPRIE Steering Committee. A randomised, blinded, trial of clopidgrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.